April 2021 Issue

GO TO FULL ISSUE

Med Updates

Verquvo
vericiguat
A guanylate cyclase stimulator for patients with symptomatic chronic heart failure and ejection fraction <45%

Cabenuva
cabotegravir/rilpivirine
A co-packaged injectable integrase strand transfer inhibitor and non-nucleoside reverse transcriptase inhibitor for HIV-1 infection

Byfavo
remimazolam
New IV benzodiazepine for procedural sedation

MORE NEW DRUGS

Get the fastest, most trustworthy advice on how drug therapy changes fit into your everyday practice. Subscribe. Prescriber's Letter

Journal Club

  • April
    Bamlanivimab Alone or With Etesevimab to Treat Outpatients With COVID-19
  • March
    Single Maintenance and Reliever Therapy for Persistent Asthma
  • February
    Sacubitril/Valsartan for Heart Failure With Preserved Ejection Fraction
  • MORE JOURNAL CLUB TOPICS